Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Designing cell-aggregating peptides without cytotoxicity.

Yamamoto N, Tamura A.

Biomacromolecules. 2014 Feb 10;15(2):512-23. doi: 10.1021/bm4014414. Epub 2014 Jan 27.

PMID:
24432760
2.

Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.

Yamamoto N, Tamura A.

Peptides. 2010 May;31(5):794-805. doi: 10.1016/j.peptides.2010.01.006. Epub 2010 Jan 28.

PMID:
20109510
3.

Effects and mechanisms of the secondary structure on the antimicrobial activity and specificity of antimicrobial peptides.

Mai XT, Huang J, Tan J, Huang Y, Chen Y.

J Pept Sci. 2015 Jul;21(7):561-8. doi: 10.1002/psc.2767. Epub 2015 Mar 30.

PMID:
25826179
4.

New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.

Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.

Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.

PMID:
18375018
5.

Effects of the hinge region of cecropin A(1-8)-magainin 2(1-12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells.

Shin SY, Kang JH, Jang SY, Kim Y, Kim KL, Hahm KS.

Biochim Biophys Acta. 2000 Feb 15;1463(2):209-18.

6.

Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides.

Schmitt MA, Weisblum B, Gellman SH.

J Am Chem Soc. 2007 Jan 17;129(2):417-28.

PMID:
17212422
7.
8.

Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units.

Ma QQ, Dong N, Shan AS, Lv YF, Li YZ, Chen ZH, Cheng BJ, Li ZY.

Amino Acids. 2012 Dec;43(6):2527-36. doi: 10.1007/s00726-012-1334-7. Epub 2012 Jun 15.

PMID:
22699557
9.
10.

Short antibacterial peptides with significantly reduced hemolytic activity can be identified by a systematic L-to-D exchange scan of their amino acid residues.

Albada HB, Prochnow P, Bobersky S, Langklotz S, Bandow JE, Metzler-Nolte N.

ACS Comb Sci. 2013 Nov 11;15(11):585-92. doi: 10.1021/co400072q. Epub 2013 Oct 30.

PMID:
24147906
11.

Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum.

Bagheri M, Beyermann M, Dathe M.

Antimicrob Agents Chemother. 2009 Mar;53(3):1132-41. doi: 10.1128/AAC.01254-08. Epub 2008 Dec 22.

12.
13.

Amphipathic alpha helical antimicrobial peptides.

Giangaspero A, Sandri L, Tossi A.

Eur J Biochem. 2001 Nov;268(21):5589-600.

14.
15.
16.

Interaction of W-substituted analogs of cyclo-RRRWFW with bacterial lipopolysaccharides: the role of the aromatic cluster in antimicrobial activity.

Bagheri M, Keller S, Dathe M.

Antimicrob Agents Chemother. 2011 Feb;55(2):788-97. doi: 10.1128/AAC.01098-10. Epub 2010 Nov 22.

17.

Cecropin A - magainin 2 hybrid peptides having potent antimicrobial activity with low hemolytic effect.

Shin SY, Kang JH, Lee MK, Kim SY, Kim Y, Hahm KS.

Biochem Mol Biol Int. 1998 May;44(6):1119-26.

PMID:
9623765
18.

De novo design of potent antimicrobial peptides.

Frecer V, Ho B, Ding JL.

Antimicrob Agents Chemother. 2004 Sep;48(9):3349-57.

19.
20.

Synthesis and antibacterial activity of peptide deformylase inhibitors.

Huntington KM, Yi T, Wei Y, Pei D.

Biochemistry. 2000 Apr 18;39(15):4543-51.

PMID:
10758004

Supplemental Content

Support Center